Nature.comPolicy: Global standards for stem-cell researchNature.comOn 12 May, in response to scientific progress and evolving ethical concerns, the International Society for Stem Cell Research (ISSCR) issued updated and extended guidelines for work inv… Continue reading
Bloomberg |
Stop Hyping Stem Cell Science, Say Stem Cell Scientists
Bloomberg New guidelines from the International Society for Stem Cell Research, which represents 4,100 researchers, urge their colleagues to be more careful when talking about science that currently has few proven medical benefits. “The stem cell research … Guidelines on stem cell research meant to ensure treatments safe and effective Stem Cells are Dangerously Overhyped, Warn Researchers When we hype our science, discoveries are diminished |
|
Oxford Spin-out raises record €21M to re-program Stem Cells
Labiotech.eu (blog) OxStem strategy for stem cells therapy inside the body could have a big impact in regenerative medicine – and it has raised €21.4M, a record for a UK spin-out. oxstem_regenerative_medicine_stem_cell_chemistry A spin-out of Oxford University, OxStem is … |
Medical Daily |
Stem Cells Of Type 1 Diabetes Patients Transformed Into Insulin-Secreting Beta Cells; Research May Lead To New …
Medical Daily The most recent attempt to take down diabetes comes from researchers at Washington University School of Medicine in St. Louis and Harvard University, who have managed to change stem cells derived from diabetes patients into insulin–secreting cells. Diabetes Treatment Using Stem Cells: No More Insulin Injection Gene Therapy for Type 1 Diabetes: Preclinical Promise |
BioPharma-Reporter.com |
Daiichi snaps up Japanese rights to CVD stem–cell therapy
BioPharma Dive Japanese drugmaker Daiichi Sankyo has bought rights to market U.K.-based Cell Therapy’s regenerative heart treatment in Japan, boosting the profile of the stem cell therapy company. Cell Therapy, founded by Nobel Prize-winner Martin Evans, will receive … Daiichi Sankyo licenses off-the-shelf regenerative heart cell therapy from CTL Cell Therapy licenses heart failure therapy in Japan Cell Therapy Ltd’s CEO Ajan Reginald talks to TPL’s Katie Osborne |